Prosecution Insights
Last updated: April 19, 2026

Hepgene Medical AB

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17647480 NOVEL NUCLEIC ACID MOLECULES AND THEIR USE IN THERAPY LIPPOLIS, ALEXANDRA ROSE 1637 Final Rejection Jan 10, 2022

Managing Hepgene Medical AB's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month